This is a regulatory disclosure submitted by Cravatex Limited to the BSE Limited, Department of Corporate Services. The purpose of the document is to intimate the exchange of a scheduled meeting of the Company's Board of Directors.
The Board Meeting is scheduled to be held on Tuesday, 3rd November, 2026. The primary agenda for the meeting is to consider and approve the company's unaudited financial results. The results to be approved are for both the standalone and consolidated entity, covering the period of the quarter and half year ended 30th September, 2026.
The letter is signed by Sudhanshu Namdeo, who holds the positions of Company Secretary and Compliance Officer for Cravatex Limited. The document was digitally signed on October 26, 2026, at 14:27:47 IST.